Author Archives: thedangerpoint

The Market Set-Up … This Week

October 16, 2022 By in $SPSIBI, Basic Materials, Bonds, David Weis, DJUSBM, Gold & Silver, IYM, IYR, J.P. Morgan, LABD, LABD-22-08, Michael Cowan, Positions, SLV, SPBIO, Spring-to-Up-Thrust, Survival Lilly, TLT, TMF, TSLA, Van Metre, Wyckoff, ZeroHedge 4 Comments

What To Watch

First off, it’s nice to know, traders at J.P. Morgan, don’t have clue as what to do.

They say it themselves; Not One Person

On top of that, I’m supposed to pay money reading about how clueless they are. 🙂

No thanks. Let’s see if we can do better than the average ‘investment firm’.

Before we get started, a reminder; as Michael Cowen says:

‘It’s the bear market that reveals those who really understand’, not the bull market ‘geniuses‘.

With that, let’s get into it; first up, is silver.

Silver: Wyckoff Analysis Results

The downside reversal was identified to the day.

Adding to that post, Europeans could not only be freezing or starving this winter, but also subject to radiation poisoning.

Surely, they’re all thinking that ‘stack’ of silver is going to save them.

Silver (along with gold) remain trending lower.

Silver (SLV) is currently at support levels; therefore, some upward action (staying below SLV: 18.5) is normal behavior.

Bonds: Are They Ready?

Hold your nose … bonds could be setting up for a rally.

As Steven Van Metre reports here, the Fed ‘shenanigan’ meter is pegged.

Bonds, TLT Weekly

Note, the bullish TLT, set-up is not confirmed until MACD ticks higher (not advice, not a recommendation).

Also note the repeating pattern of ‘spring to up-thrust‘.

Last up, biotech

Biotech SPBIO, Hourly (Inverted)

We’re going to use the chart from yesterday’s post to set the stage for getting closer-in.

This past Friday’s early morning ‘spike’ is barely visible; the 30-minute (inverted) chart below, has more detail.

SPBIO, 30-minute (Inverted)

Price action rejected the lower levels (higher on SPBIO) and pulled away throughout the session. That ‘pulling away’ continued on, all the way into the close.

That’s a clue there may be follow-through at the next session.

If the early session opens ‘gap-higher’ (SPBIO, lower), into the resistance area (four magenta arrows, hourly chart), it would be the fourth time pressuring at this area; markets rarely hold a fourth attempt.

Summary

Of course, other markets are being watched like real estate (IYR), Tesla (TSLA), and even Basic Materials (DJUSBM), a potential sleeper for significant downside.

Updates are planned if/when low risk shows up.

Positions: Current Stance (courtesy only, not advice).

The following is the positioning of my firm’s main (largest) account.

LABD-22-08:

LABD Entry @ 25.1278, 24.735, 26.025, 22.99, 22.29***, Stop is @ LABD 21.23***

***, Indicates change

Note: Positions may be increased, decreased, entered, or exited at any time.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The Usual Suspects

October 15, 2022 By in $SPSIBI, Biotech, Dr. Elder, Gwen Olsen, LABD, LABD-22-08, Livermore, Positions, SPBIO, The Epoch Times, The Speck, Usual Suspects, ZeroHedge 1 Comment

Special Biotech Edition

Bogart

An immense flood of data; research reports, lawsuits, expose articles and anecdotal evidence; every day, multiple times a day, something new.

Has the biotech technical (finally) lined up with the fundamental?

Those fundamentals are farther down but first, we’ll discuss the technical.

As a reminder, sometimes charts are inverted during analysis. This ‘trick’ was discovered years ago and is based on techniques used by Dr. Alexander Elder.

Biotech SPBIO, Weekly Close (Inverted)

We’ve taken the weekly closing chart of SPBIO ($SPSIBI, on StockCharts) and inverted it to mimic the action of inverse fund LABD.

The index has no volume; so LABD is used instead.

The magenta arrow shows the pivot point for the index, corresponds will all-time record volume on leveraged inverse LABD.

Next, we’ll get closer-in and look at the ‘pivot’ on the hourly chart (inverted).

SPBIO, Hourly (Inverted).

The magenta arrows show successive positions (Livermore ‘probes’) entered (via LABD) before the main entry @ LABD 22.99, which was 90% of position size up to that point.

The next day (Friday) had a gap-lower open that was quickly reversed. Position size was increased by another 5%, at LABD 22.29 (not advice, not a recommendation).

Effective position equates to LABD 23.17

Price action pulled away steadily from the early morning levels, suggesting a sustainable reversal.

The Fundamentals

Some of this stuff, you just can’t make up.

Listed in somewhat chronological order, here they are (not an exhaustive list).

No. 1

Pfizer hires 600 to help document adverse events. Wasn’t it supposed to be ‘safe and effective’?

No. 2

Pilot Shortage

Fired/quit because they refuse to get ‘protection’.

A possible corollary to what’s happened, via injection, we have this.

No. 3

Pfizer, nobody wants their product … after the rollout.

No. 4

Who could it be?

Previously unknown (or rare) problems and illness now starting to accelerate.

No. 5

We’re here to help.

No. 6

You mean, it was all a lie?

No. 7

The real reason for getting ‘tested’?

No. 8

What did the media know and when did they know it?

No. 9

It’s still a ‘suggestion‘ but the payouts to family members are real.

No. 10

It’s over … and then it’s not.

No. 11

We’ll keep it quiet, so no feelings get hurt.

No. 12

How bad is your batch? Let’s see.

No. 13

You mean, it was never tested? I’m shocked.

No. 14

After all that, maybe we can give it another shot.

No. 15

A potential infinite number of complications … nothing to see here.

No. 16

Getting away with it? Not so fast.

No. 17

Just had a heart attack? We can help.

No. 18

Limited Hangout? You decide.

No. 19

Lastly, this is what it’s really all about.

Recorded years ago. Did her ‘prophecy’ come true?

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Wheels Come Off … Biotech

October 13, 2022 By in $SPSIBI, Biotech, DRV, DRV-22-04, GDX, GDXJ, IYR, LABD, LABD-22-08, Positions, S&P, S&P 500, SPBIO, SPY, The Epoch Times, ZeroHedge

Unraveling, Quickly

This just out on ZeroHedge:

An Epoch Times article, using excerpts from a Lancet Report, linked here.

It’s best to let the reader sort out what it all means, arriving at one’s own conclusions.

Of course, the obvious problem, the ‘elephant’ is not addressed directly.

However, VAERS is quoted in The Epoch Times article, thus giving it legitimacy.

Leading The Downside

For some time, this site’s highlighted, biotech (SPBIO), as unique to all other indices save GDX, and GDXJ.

That is, it’s down the most since the bear market started.

As of today’s close, it’s down over – 54%, from all-time highs while the S&P is down only – 23.7%.

As documented over several years, the sector’s unique; it’s at risk (more than other indices) to implosion.

With today’s close, it looks like we’re at a critical juncture.

Biotech SPBIO, Weekly

The unmarked weekly chart

Compressed, with added trendlines.

It’s an obvious trading channel of immense size … but so is nearly everything else concerning these markets. We’re operating at unprecedented scale in unprecedented times.

But wait, there’s more.

The trading channel has Fibonacci time correlation(s).

We’ll expand the weekly chart for more clarity.

From channel entry, week ending 9/3/21, to the right-most contact point (week ending 9/16/22), is Fibonacci 55-Weeks.

Channel width measured from week ending 1/28/22, to the same contact-point, week ending 9/16/22, is a Fibonacci 34-Weeks.

We’re at The Danger Point®

Positions & Current Stance (courtesy only, not advice).

The following is the positioning of my firm’s main (largest) account.

DRV-22-04:

Entry @ 66.463, Stop @ 63.98

Discretionary exit (today) @ 75.96***

Trade Closed

LABD-22-08:

Entry @ 25.1278, 24.735, 26.025***, 22.99***, Stop is Open (to be set at next session)

***, Indicates change

Note: Positions may be increased, decreased, entered, or exited at any time.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Real Estate Crash … Exit Targets

October 11, 2022 By in DRV, DRV-22-04, Gold & Silver, IYR, LABD-22-08, Real Estate, SLV, SPBIO, zsl, ZSL-22-01

The DRV, Exit(s)

Well-calculated stops, (mostly) take care of trade implosion. So, where’s the exit?

The answer is there’s no set answer.

We’ll explain that by using the current plan for DRV-22-04 (not advice, not a recommendation).

Questions

First question to determine an exit in this case, is to ask:

“What are the media pundits, and/or ‘experts’ talking about right now?”

Well, that’s easy.

Just like the ‘silver squeeze’ idea that won’t go away (even as SLV continues downward), the ‘Fed pivot‘ is another delusion that keeps holding on.

As parts of the market (like IYR) continue their free-fall, all eyes are on the next Fed meeting; waiting for them to pivot and ‘save us’.

Right around November 1st, or 2nd, seems like it can’t help but be some kind of emotional cathartic set-up.

Unless stopped out ahead of time, the plan, is to plan an exit within that window.

Let’s go to the IYR, 3X Leveraged Inverse fund DRV.

IYR, 3X Inverse, DRV, Daily

At the end of today’s session DRV has posted a downside reversal candle.

The next session will be important.

We either have follow-through to the downside, thus validating the reversal (and exit of the position) or we have some variation of an inside day or new daily high.

If the trading channel remains valid, the compressed chart below shows a potential exit range: DRV 140 – 200.

During the next session(s), if DRV, posts a new daily high (unless stopped), the DRV-22-04, stop will be moved to this session’s low @ 73.86

Positions & Current Stance (courtesy only, not advice).

The following is the positioning of my firm’s main (largest) account.

DRV-22-04:

Entry @ 66.463, Stop @ 63.98

ZSL-22-01:

Entry @ 28.08, Stop @ 28.53:

Discretionary exit (today) @ 31.5513***

Trade Closed

LABD-22-08***:

Entry @ 25.1278 (yesterday) and 24.735 (today), Stop @ 22.59

***, Indicates change

Note: Positions may be increased, decreased, entered, or exited at any time.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Silver … Sold Out !

October 10, 2022 By in Dollar, Gold & Silver, Kitco, SD Buiilion, Silver Collapse, SLV, Spring-to-Up-Thrust, Uneducated Economist, Wyckoff

… And The Bulls Are Trapped

How is it possible to have silver stocks sold out here and here, yet silver bears have trapped the bulls.

As we’ll show below, this morning’s action in SLV, has confirmed the reversal; a Wyckoff up-thrust, pointing silver’s probability to lower levels.

For starters, let’s recap on how this (trading) game is played.

That is, the public i.e., the masses, need to be led to and fro so they are continuously on the wrong side of the trade.

That’s it.

So it is with precious metals and specifically silver.

The media came out recently, effectively telling everyone ‘Now is the time to buy gold’.

Where were these guys in 2001, when gold bottomed around $271/oz.

No, they show up at the end of the move … not the start.

Public Buys Hype, Not Facts

So the public has bought into the hype and run the silver coffers dry. Everyone excepts an immediate currency collapse and certainly anything can happen.

However, as Undedicated Economist points out, the dollar strength (first identified in this post) can last for years.

The original (bullish reversal) analysis is now supported by the facts; it’s been nearly two-years since that post and the dollar (UUP) is still headed higher.

So, let’s find out where silver is likely to go. For that, we go to the weekly chart.

Silver SLV, Weekly

The set-up, already posted; Spring-to-Up-Thrust.

It’s a repeating pattern found across the markets.

Price action gets itself into a spring condition by penetrating support which subsequently sets up the reversal; the up-thrust.

Next, we’ll use the Fibonacci Projection Tool, showing likely areas for downside destination.

A full 1 : 1 projection gets us right back to where we started the whole ‘short-squeeze’.

If SLV, gets back down to the 10.50 – 11.0, level, one can only imagine what type of hype will be in vogue.

However, at those levels, it’s reasonable to expect the local bullion dealer will be begging for sales … they might even offer their product at, or near, spot. 🙂

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Sentiment Shift … Biotech

October 9, 2022 By in $SPSIBI, Biotech, SPBIO, Tim Truth, Ukraine, ZeroHedge

Was Friday, The Day?

Is the tide (finally) going out for biotech?

The end of the prior update, shows a lot coming to the surface.

So much, that it can’t be ignored.

Also coming out on Friday, was this report.

Is it all too much, price action has finally reversed? We’ll analyze that potential below.

Biotech SPBIO, Quarterly

First, the big picture.

There have been six consecutive lower quarters … the most of any major index

What’s not labeled above, is an apparent Head & Shoulders pattern forming; the arrow showing the rejection of the upward move could be the top of the Right Shoulder.

The left shoulder is considered to be the eight quarters that span, 6/29/18 – 3/31/20.

If it’s an H&S, and if the support is penetrated, the measured move target is shown.

That’s a lot of ‘ifs’.

Moving on to the weekly, we see confirmation of the right-side trendline. Also shown is the potential trading channel.

Biotech SPBIO, Weekly

Price action could still break out to the upside from the channel line.

For that to happen, there would need to be some kind of huge catalyst.

So far, nothing out of the ordinary other than the typical Ebola outbreak and/or, radiation poisoning 🙂

Downside Reversal Probabilities

So, last Friday was decidedly down. If we’re in a reversal, what’s the next likely thing to happen?

For that answer, we go to the daily chart.

Biotech SPBIO, Daily

The blue lines are a minor support zone.

If we are in a reversal, a lower open at the next session (into the support zone) weights probabilities to the downside.

If that happens, expect price action to attempt to ‘test’ Friday’s wide bar by moving higher … at least temporarily.

If there’s a higher open instead, it does not necessarily negate the reversal, but it does weaken the case.

It may mean there’s more upside testing and/or, the beginnings of a move to much higher levels.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Tesla … Set To Implode

October 8, 2022 By in Biotech, LABD, LABD-22-07, Mass Psychosis, Taleb, Texas Freeze, The Speck, TSLA, TSLL, TSLS, Wyckoff 3 Comments

Watch The Tape

Two-year uptrend, broken.

A year’s-worth of ‘distribution’ from strong hands to weak.

Ten days from now is the next TSLA, earnings release.

With TSLA, price action approaching The Danger Point®, that earnings release is likely to be a catalyst.

The monthly chart has the trendline (and channel) break along with the distribution phase.

Tesla TSLA, Monthly

Note, each thrust attempt higher (magenta arrows) has subsequently failed.

Thrusts following the first one, are at lower levels.

The weekly chart below, shows what we’re looking for; penetration of support to potentially set up a short-trade (not advice, not a recommendation).

Tesla TSLA, Weekly

When or if that penetration takes place, depending on the depth of the thrust, we’ll have a Wyckoff spring set up … that ultimately is expected to fail.

Ways To Trade

As if on cue and possibly in anticipation of TSLA fireworks, there’s a long and short ETF, for just this ticker.

Released just months ago; TSLS, a 1X inverse (bear) TSLA. The bull side has 1.5X leverage with TSLL.

TSLS, has a 100% maintenance requirement and TSLL, has the same.

Or, one can short directly.

There’s no dividend and the broker used by my firm shows TSLA, has no borrowing restrictions other than a 40% maintenance requirement (not advice, not a recommendation).

Then, there are options … we’ll discuss those if some kind of high probability opportunity presents itself.

The Masses

Let’s not forget the herd. What are they doing/saying?

With that in mind, a random check of our favorite holding pen, SeekingAlpha, has oodles of TLSA analysis.

The most recent is actually quite good from a thoroughness perspective. It admits/discusses the downward pressures and identifies the support/resistance levels discussed above.

The problem is the mass psychosis.

It’s the ‘EVs are the way’ mantra as if Bhagwan Shree Rajneesh himself, was communicating directly.

With the winter carnage in Europe just weeks away, we’re about to find out how green ‘electrics’ hold up when there is, well, no electricity.

Back to Biotech

While all of the above is transpiring, the real Black Swan continues to emerge; the latest here, here and here.

This event is happening now; the effects of which will last our lifetimes.

It’s massive and world-wide; likely to override any mainstream (traditional 60/40, type) analysis.

After letting go of the biotech short for the seventh time, two days later, this past Friday, it decides to reverse.

We’ll cover that in the next update.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

ProLogis … Real Estate Proxy

October 7, 2022 By in 2007 - 2008, AMT, DRV, DRV-22-04, IYR, PLD, Positions, zsl, ZSL-22-01

The Work Has Already Been Done

This is how it pays off.

Work was done months ago, on ProLogis (logistics/warehouse, real estate) which at the time, was the largest cap in the IYR.

It’s now No.2, just behind AMT, but the effort is still valid.

From that post last May, the behavior of ProLogis during a bear market was summed up with the following:

“It’s straightforward.

Using 2008 – 2009, timeframe as the proxy, PLD was vaporized; straight down for two-months.”

Well, that was back in ’08 – ’09.

Let’s see how our ‘vaporization’ is going now.

ProLogis PLD, Monthly

Price action is at support.

Downward pressure is immense.

We should all be able to agree, this time is worse than last time (’08 – ’09).

There’s no money left for a ‘save’, and our chief cook and bottle washer, the Fed, seems to be on a different agenda.

So, let’s remind ourselves of the potential for this down-move should it come to fruition.

The weekly chart of PLD, and distance traveled below the 200-wk Moving Average, gives us a sense of the enormity.

ProLogis PLD, Weekly

To position for a potential event, there may be plenty of time, or no time.

Either way, when things really get started to the downside, confusion, panic, locked-up brokerages, internet outages, will likely be the norm.

Positions & Current Stance (courtesy only, not advice).

The following is the positioning of my firm’s main (largest) account.

DRV-22-04:

Entry @ 66.463, Stop @ 63.98

ZSL-22-01:

Entry @ 28.08, Stop @ 28.53***

***, Indicates change

Note: Positions may be increased, decreased, entered, or exited at any time.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Real Estate ‘Crash Channel’

October 6, 2022 By in 2007 - 2008, DRV, DRV-22-04, IYR, Positions, Real Estate

Not Saying That Lightly

For real estate, the crash may be happening as we speak.

Even if it’s not, the sector (IYR) has developed an aggressive trading channel as we’ll see below.

First, we’ll look at ‘big picture’ potential on the weekly chart.

Real Estate IYR Weekly

The distance traveled from the 200 Week Moving Average during the crash of ’08 – ’09, is shown.

That same distance is projected on the current situation.

Everybody’s ‘looking for the bottom’ … well, there it is. 🙂

Of course, that’s only a potential bottom.

Where it gets really scary is the channel that’s been confirmed on the daily chart, shown below.

The zoom version shows the weak blip higher … potential short covering that looks complete.

One caveat is that as (or if) IYR price action approaches the lows, technically speaking, it’s a support level.

That’s the time to watch the right-side channel line to see if it’s penetrated, thus negating the aggressive downtrend.

Positioning

Everyone has their own style and this is NOT financial advice.

However, a short was initiated early this session in Leveraged Inverse Fund DRV, labeled DRV-22-04.

Opened @ 66.4633, with a stop at session low, 63.98

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

After The Close …

October 5, 2022 By in Biotech, LABD, LABD-22-07, SPBIO, Spring-to-Up-Thrust, Wyckoff, zsl, ZSL-22-01 1 Comment

The Tape Is Always Right

Once again, stopped-out of the biotech short (not advice, not a recommendation).

Call it bad timing, incorrect analysis or whatever. Every opportunity for SPBIO, to go lower is being thwarted … so, no more for now.

On the flip side, the potential collapse in silver has been discussed over the past few weeks, here, here, here and here.

Looking at the chart below, not only do we have a Wyckoff Up-Thrust, but unless it’s negated by subsequent price action, we’ve got an ‘island gap reversal’ as well.

Prices can’t be sustained at yesterday’s higher level.

Silver SLV, Daily

As previously discussed, very late in the session as SLV, price action rose higher, reducing the risk, a short was entered via Leveraged Inverse Fund ZSL @ 28.08 (not advice, not a recommendation).

The trade is identified as ZSL-22-01.

An obvious hard-stop would be yesterday’s high in SLV, or the corresponding low in ZSL @ 26.55.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279